The Comparison of the Effect of Chemical Peeling with Tretinoin 1% and Glycolic Acid 70% on the Treatment of Melasma in Women

Document Type : Original Article(s)

Authors

1 Associate Professor, Department of Dermatology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

2 Medical Student, Isfahan University of Medical Sciences, Isfahan, Iran.

Abstract

Background: Melasma is an irregular brown pigmentation, especially in Asian middle-aged women that may cause several psychological problems. Peeling with Glycolic acid 70% (GA) is one the melasma treatment methods. Considering the efficiency of low concentrations Tretinoin in lightening daily cream, peeling with higher concentrations of Tritenoin in a shorter time may be more effective than topical treatments to eliminate melasma. This study was done to compare the effect and side effects of Tritenoin peeling with Glycolic acid 70%.Methods: This study was a randomized double-blind clinical trial in 63 women with bilateral melasma. One percent Tretinoin peel was applied on one-half of the face, whereas 70% glycolic acid was applied on the other in 4 sessions with 2 weeks interval. At the same time, Melasma Area and Severity Score (MASI Score), side effects and patients tolerence were compared.Finding: Tretinoin 1% effectiveness in reducing MASI Score and its side effects, patient satisfaction and onset of treatment was the same as Glycolic acid 70% (P < 0.05 in all). Discomfort caused by the peeling action of Tretinoin 1% was significantly less than Glycolic acid 70% (P < 0.05).Conclusion: Regarding the effectiveness of similar onset of treatment, similar side effects and minimal discomfort during and after peeling and also cheaper prices of Tretinoin 1% compared with Glycolic acid 70%, Tretinoin 1% can be a suitable method for treatment of melasma.

Keywords

References

  1. Sanchez NP, Pathak MA, Sato S, Fitzpatrick TB, Sanchez JL, Mihm MC Jr. Melasma: a clinical, light microscopic, ultrastructural, and immunofluorescence study. J Am Acad Dermatol 1981; 4(6): 698-710.
  2. Breathnach AS. Melanin hyperpigmentation of skin: melasma, topical treatment with azelaic acid, and other therapies. Cutis 1996; 57(1 Suppl): 36-45.
  3. Grimes PE, Yamada N, Bhawan J. Light micro-scopic, immunohistochemical, and ultrastructural alterations in patients with melasma. Am J Dermatopathol 2005; 27(2): 96-101.
  4. Kang WH, Yoon KH, Lee ES, Kim J, Lee KB, Yim H, et al. Melasma: Histopathological characteristics in 56 Korean patients. Br J Dermatol 2005; 146(2): 228-37.
  5. Nikolaou V, Stratigos AJ, Katsambas AD. Established treatments of skin hypermelanoses. J Cosmet Dermatol 2006; 5(4): 303-8.
  6. Guevrana IL, Pandya AG. Melasma treated with Hydroquinone tretinoin and a fluorinated steroid. Int J Dermatol 2001; 40(3): 212-5.
  7. Lee JH, Park JG, Lim SH, Kim JY, Ahn KY, Kim MY, et al. Localized intradermal mi-croinjection of tranexamic acid for treatment of melasma in Asian patients: a preliminary clinical trial. Dermatol Surg 2006; 32(5): 626-31.
  8. Rubin MG. Procedures in Cosmetic Dermatology Series: Chemical Peels. Philadelphia: WB. Saunders; 2005.
  9. Clark CP 3rd. Office-based skin care and superficial peels: the scientific rationale. Plast Reconstr Surg 1999; 104(3): 854-64, discussion 865-6.
  10. Salvin JW. Considerations in alpha hydroxy acid peels. Clin Plas Surg 1998; 25(1): 45-52.
  11. Cuce LC, Bertino MC, Scattone L, Birkenhauer MC. Tretinoin peeling. Dermatol Surg 2001; 27(1): 12-4.
  12. Khunger N, Sarkar R, Jain RK. Tretinoin peels versus glycolic acid peels in the treatment of Melasma in dark-skinned patients. Dermatol Sug 2004; 30(5): 756-60.
Journal of Isfahan Medical School
Volume 28, Issue 115 - Serial Number 115
September and October 2011
Pages 980-986

Files

History

  • Receive Date: 03 March 2011
  • Revise Date: 29 April 2024
  • Accept Date: 06 April 2022

Share

How to cite

Statistics